பாரதியா ஜனதா கட்சி வழிநடத்தியது மைய News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Farm laws: My comments asking farmers to move protests given a political twist : Punjab CM
scroll.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scroll.in Daily Mail and Mail on Sunday newspapers.
Haryana Congress stages protest against Pegasus spyware snooping
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
Delhi Deputy Chief Minister Manish Sisodia addressing a digital press meet on Tuesday.
What is role of Centre if states have to procure COVID vaccine from global market, asks Sisodia ANI | Updated: May 11, 2021 20:39 IST
New Delhi [India], May 11 (ANI): Reacting to Bharatiya Janata Party-led Central government accusations on Delhi government of not floating a global tender to buy vaccines, Delhi Deputy Chief Minister Manish Sisodia asked if states are supposed to go to international market to procure COVID vaccines what is the role of the Centre. BJP says that Delhi government should have floated an international tender to buy vaccines from the international market. Does this mean that all State govts should go to international markets to buy vaccines?, the Deputy CM said at a virtual press meet on Tuesday evening.
It is said that India’s ruling regime is working tirelessly to realize its dream of ‘one nation, one party’. Strangely, the Bharatiya Janata Party-led Central government does not seem to be equally enthusiastic about ‘one nation, one price’ for the coronavirus vaccines. The newly-minted vaccination policy announced by the Centre has led to such speculation. The Narendra Modi government has said that from May 1, the Centre would only procure 50 per cent of the doses, permitting vaccine manufacturers to sell the remaining batches of medicine to state governments and private hospitals at variable prices. The results are there for all to see. Covaxin, the indigenous drug, is set to be available at Rs 1,200 per dose in private hospitals; Covishield the AstraZeneca drug that is being produced by Serum Institute of India would, reportedly, be sold at Rs 400 per dose for state governments and Rs 600 per vial for private hospitals. Apparently, the pricing is sensitive to investm
vimarsana © 2020. All Rights Reserved.